A stepped wedge cluster randomized control trial of dried blood spot testing to improve the uptake of hepatitis C antibody testing within UK prisons

Background: The prevalence of hepatitis C (HCV) is elevated within prison populations, yet diagnosis in prisons remains low. Dried blood spot testing (DBST) is a simple procedure for the detection of HCV antibodies; its impact on testing in the prison context is unknown. Methods: We carried out a stepped-wedge cluster-randomized control trial of DBST for HCV among prisoners within five male prisons and one female prison. Each prison was a separate cluster. The order in which the intervention (training in use of DBST for HCV testing and logistic support) was introduced was randomized across clusters. The outcome measure was the HCV testing rate by prison. Imputation analysis was carried out to account for missing data. Planned and actual intervention times differed in some prisons; data were thus analysed by intention to treat (ITT) and by observed step times. Results: There was insufficient evidence of an effect of the intervention on testing rate using either the ITT intervention time (OR: 0.84; 95% CI: 0.68–1.03; P = 0.088) or using the actual intervention time (OR: 0.86; 95% CI: 0.71–1.06; P = 0.153). This was confirmed by the pooled results of five imputed data sets. Conclusions: DBST as a stand-alone intervention was insufficient to increase HCV diagnosis within the UK prison setting. Factors such as staff training and allocation of staff time for regular clinics are key to improving service delivery. We demonstrate that prisons can conduct rigorous studies of new interventions, but data collection can be problematic. Trial registration: International Standard Randomized Controlled Trial Number Register (ISRCTN number ISRCTN05628482).

[1]  W. Cleveland Robust Locally Weighted Regression and Smoothing Scatterplots , 1979 .

[2]  S. Gore,et al.  Prevalence of hepatitis C in prisons: WASH-C surveillance linked to self-reported risk behaviours. , 1999, QJM : monthly journal of the Association of Physicians.

[3]  J. Hughes,et al.  Design and analysis of stepped wedge cluster randomized trials. , 2007, Contemporary clinical trials.

[4]  M. Murtagh,et al.  'I just keep thinking I haven't got it because I'm not yellow': a qualitative study of the factors that influence the uptake of Hepatitis C testing by prisoners , 2007, BMC public health.

[5]  J. Parry,et al.  Improvingblood‐borne viral diagnosis; clinical audit of the uptake of dried blood spot testing offered by a substance misuse service , 2009, Journal of viral hepatitis.

[6]  Stef van Buuren,et al.  MICE: Multivariate Imputation by Chained Equations in R , 2011 .

[7]  F. Altice,et al.  A Prospective Controlled Trial of Routine Opt-Out HIV Testing in a Men's Jail , 2009, PloS one.

[8]  R. Tedder,et al.  Hepatitis B transmission event in an English prison and the importance of immunization. , 2011, Journal of public health.

[9]  J. Parry,et al.  Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. , 2000, Communicable disease and public health.

[10]  P. Drennan,et al.  Screening for hepatitis C virus in the Dartmoor prison population: an observational study. , 2004, Journal of public health.

[11]  M. Petticrew,et al.  Developing and evaluating complex interventions: the new Medical Research Council guidance , 2008, BMJ : British Medical Journal.

[12]  C. Adams,et al.  The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) prisons project: a randomised controlled trial comparing dihydrocodeine and buprenorphine for opiate detoxification , 2009, Substance abuse treatment, prevention, and policy.

[13]  S. Gore,et al.  Anonymous HIV surveillance with risk factor elicitation at Scotland's largest prison, Barlinnie , 1995, AIDS.

[14]  P. Vickerman,et al.  Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons , 2013, BMJ Open.

[15]  S. Gore,et al.  Hepatitis B outbreak at Glenochil prison during January to June 1993 , 1998, Epidemiology and Infection.

[16]  F. Altice,et al.  Routine Opt-Out HIV Testing Strategies in a Female Jail Setting: A Prospective Controlled Trial , 2009, PloS one.

[17]  W. Edmunds,et al.  The cost‐effectiveness of screening and treatment for hepatitis C in prisons in England and Wales: a cost‐utility analysis , 2008, Journal of viral hepatitis.

[18]  T. Nichols,et al.  Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial , 2008, Journal of viral hepatitis.

[19]  J. Wrench,et al.  A lasting public health response to an outbreak of HIV infection in a Scottish prison? , 1998, International journal of STD & AIDS.

[20]  Eric R. Ziegel,et al.  Generalized Linear Models , 2002, Technometrics.

[21]  W. Edmunds,et al.  Estimating the cost-effectiveness of detecting cases of chronic hepatitis C infection on reception into prison , 2006, BMC public health.

[22]  Stef van Buuren,et al.  Flexible Imputation of Missing Data , 2012 .

[23]  S. Hutchinson,et al.  Incidence of hepatitis C virus infection and associated risk factors among Scottish prison inmates: a cohort study. , 2004, American journal of epidemiology.

[24]  H. Waal,et al.  Treatment research in prison: Problems and solutions in a randomized trial , 2009 .

[25]  M. Hickman,et al.  Low incidence of hepatitis C virus among prisoners in Scotland. , 2013, Addiction.

[26]  B. Evans,et al.  Hepatitis C and B testing in English prisons is low but increasing. , 2011, Journal of public health.

[27]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[28]  J. Shearer,et al.  Evaluation of a prison‐based naltrexone program , 2007 .

[29]  Elizabeth Allen,et al.  Process evaluation in randomised controlled trials of complex interventions , 2006, BMJ : British Medical Journal.

[30]  P. Roderick,et al.  Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy , 2003, Gut.

[31]  R. Brettle,et al.  Injecting drug users in Edinburgh have a high rate of recidivism. , 2000, Addiction.

[32]  J. Parry,et al.  Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots , 2003, Journal of medical virology.

[33]  D. Jones,et al.  Audit into Blood-Borne Virus Services in Her Majesty's Prison Service , 2008, International journal of STD & AIDS.